cbdMD, Inc. (YCBD) Financials

YCBD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 12.3 million 3.0 million
Dec. 31, 2025 11.8 million 2.8 million
Sept. 30, 2025 10.4 million 3.2 million
June 30, 2025 9.9 million 3.8 million

YCBD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -728250 294445
Dec. 31, 2025 -164.8 million 2505
Sept. 30, 2025 -243553 10428
June 30, 2025 -705675 825

YCBD Net Income

No data available :(

YCBD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.6 million - 407811
Dec. 31, 2025 3.4 million - 593026
Sept. 30, 2025 2.3 million - 778240
June 30, 2025 1.1 million - 962738

YCBD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 10.4 million
Dec. 31, 2025 9.0 million
Sept. 30, 2025 8.9 million
June 30, 2025 5.8 million

YCBD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5750 2899 3.6 million -
Dec. 31, 2025 164.8 million 808 2.8 million 1.1 million
Sept. 30, 2025 2804 15022 2.8 million 1.1 million
June 30, 2025 1475 9564 3.0 million 1.3 million

YCBD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 5.6 billion 2.4 billion
Dec. 31, 2025 5.0 million 2.0 million
Sept. 30, 2025 4.7 million 1.9 million
June 30, 2025 4.6 million 1.8 million

YCBD

Price: $0.57

52 week price:
0.47
2.56

Payout Ratio Range:
-74.84%
36.45%

Earnings Per Share: 2.46 USD

P/E Ratio: 0.30

Exchange: ASE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 457300

Market Capitalization: 7.3 million

Links: